MORGAN STANLEY - ARCTURUS THERAPEUTICS LTD ownership

ARCTURUS THERAPEUTICS LTD's ticker is ARCT and the CUSIP is M1492T105. A total of 21 filers reported holding ARCTURUS THERAPEUTICS LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ARCTURUS THERAPEUTICS LTD
ValueSharesWeighting
Q1 2019$479,000
+47.8%
70,078
-2.1%
0.00%
Q4 2018$324,000
-23.6%
71,582
+49.2%
0.00%
Q3 2018$424,000
-5.4%
47,965
-9.2%
0.00%
Q2 2018$448,000
+109.3%
52,823
+35.9%
0.00%
Q1 2018$214,000
-21.0%
38,862
+13.9%
0.00%
Q4 2017$271,00034,1260.00%
Other shareholders
ARCTURUS THERAPEUTICS LTD shareholders Q4 2018
NameSharesValueWeighting ↓
Worth Venture Partners, LLC 32,848$290,0000.22%
ARK Investment Management 773,772$6,840,0000.21%
ROYCE & ASSOCIATES LP 106,436$941,0000.01%
Independence Bank of Kentucky 607$5,0000.00%
OXFORD ASSET MANAGEMENT LLP 18,700$164,0000.00%
UNITED CAPITAL FINANCIAL ADVISORS, LLC 27,300$241,0000.00%
GROUP ONE TRADING, L.P. 4,086$36,0000.00%
1832 Asset Management L.P. 560$5,0000.00%
CITIGROUP INC 171$2,0000.00%
MORGAN STANLEY 47,965$424,0000.00%
View complete list of ARCTURUS THERAPEUTICS LTD shareholders